Gene · 3908
Papers2,255
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,255
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CRPPA exon 6-9 deletion as a founder mutation in Chinese patients with dystroglycanopathy. | Pediatr Investig | 2026 | 41726576 | PubTator, text mining | PubMed |
| Glomerular basement membrane structural integrity dictates trans-tissue deposition of laminin in the kidney. | Cell Rep | 2026 | 41712384 | PubTator, text mining | PubMed |
| LINE-1 Transcript Heterogeneity in Non-Small Cell Lung Cancers Is Driven by Host Genomic Context and Conserved Functional Hotspots. | Cancers (Basel) | 2026 | 41681929 | PubTator, text mining | PubMed |
| Dual AAV gene therapy using laminin-linking proteins ameliorates muscle and nerve defects in LAMA2-related muscular dystrophy. | Mol Ther | 2026 | 41635088 | PubTator, text mining | PubMed |
| Muscle transcriptome profiling reveals novel molecular pathways and biomarkers in laminin-α2 deficient patients. | Acta Neuropathol Commun | 2026 | 41630090 | PubTator, text mining | PubMed |
| FAP expression as a marker of malignant transformation enabling in vivo characterization in peripheral nerve sheath tumors: a multimodal and translational study. | Acta Neuropathol | 2026 | 41591566 | PubTator, text mining | PubMed |
| POSTN⁺ cancer-associated fibroblast-CCL3⁺ macrophage crosstalk defines the immune-excluded tumor microenvironment in clear cell renal cell carcinoma. | Transl Oncol | 2026 | 41579565 | PubTator, text mining | PubMed |
| Free-floating long-term vascularized mesenchymal organoids. | iScience | 2026 | 41568151 | PubTator, text mining | PubMed |
| Stack: In-Context Learning of Single-Cell Biology. | bioRxiv | 2026 | 41542582 | PubTator, text mining | PubMed |
| Drivers of systemic male-female allele frequency divergence in humans. | bioRxiv | 2026 | 41542494 | PubTator, text mining | PubMed |
| Efficient LAMA1 Gene Activation by Epigenome Editing as a Therapeutic Approach for LAMA2-CMD. | Hum Gene Ther | 2026 | 41439338 | PubTator, text mining | PubMed |
| High-Penetrance Rare Variants Underlying Familial Lung Cancer Risk: Insights From Genetic Epidemiology of Lung Cancer Consortium. | J Thorac Oncol | 2026 | 41390056 | PubTator, text mining | PubMed |
| Exploring the blood-testis-barrier dynamics by targeting Laminin-α2: ADMET, molecular docking, and dynamics simulation study. | J Reprod Immunol | 2026 | 41349263 | PubTator, text mining | PubMed |
| DNMT1-mediated LAMA2 inhibition induces M2 macrophage polarization during prostate cancer progression. | Tissue Cell | 2026 | 41045637 | PubTator, text mining | PubMed |
| Structural and functional consequences of non-synonymous SNPs within the LAMA2 protein: a molecular dynamics perspective. | J Biomol Struct Dyn | 2026 | 39522170 | PubTator, text mining | PubMed |
| LAMA2 variants associated with muscular dystrophy, brain structural abnormalities, and epilepsy: a genotype-phenotype study. | Front Neurol | 2025 | 41567540 | PubTator, text mining | PubMed |
| Integrating the Data From Microbiome and Metabolome Genome-Wide Association Studies to Uncover Gene-Microbe-Metabolite Interactions in Allergic Diseases. | Cureus | 2025 | 41561239 | PubTator, text mining | PubMed |
| Conserved Neuronal-like and Secretory Programs Define the Spatial Architecture of Gastroenteropancreatic Neuroendocrine Tumors. | bioRxiv | 2025 | 41509223 | PubTator, text mining | PubMed |
| Biomimetic fractal topography enhances podocyte maturation in vitro. | Nat Commun | 2025 | 41398144 | PubTator, text mining | PubMed |
| Loss of cell-autonomously secreted laminin-α2 drives muscle stem cell dysfunction in LAMA2-related muscular dystrophy. | Nat Commun | 2025 | 41309582 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3908/papers?page=3